Highlights of ASRS and EVRS 2006
The combined meetings of the American Society of Retina Specialists (ASRS) and the European Vitreoretinal Society (EVRS) took place in Cannes, France, from September 9-13, 2006. With the recent US Food and Drug Administration (FDA) approval of ranibizumab and the widespread use of bevacizumab for age-related macular degeneration (AMD), a great deal of the program was devoted to antiangiogenesis, highlighted by an outstanding featured guest lecture by Judah Folkman, MD. Other topics of note included advances in surgical instrumentation and treatment of diabetic macular edema.
The combined meetings of the American Society of Retina Specialists (ASRS) and the European Vitreoretinal Society (EVRS) took place in Cannes, France, from September 9-13, 2006. With the recent US Food and Drug Administration (FDA) approval of ranibizumab and the widespread use of bevacizumab for age-related macular degeneration (AMD), a great deal of the program was devoted to antiangiogenesis, highlighted by an outstanding featured guest lecture by Judah Folkman, MD. Other topics of note included advances in surgical instrumentation and treatment of diabetic macular edema.
SHARE
